These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7259814)

  • 1. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
    Ballantyne D; Ballantyne FC; McMurdo
    Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
    Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW; Holden E
    J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
    Levenstein JH
    S Afr Med J; 1981 Jun; 59(25):893-9. PubMed ID: 7015537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1979 Jan; 55(4):114. PubMed ID: 424946
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
    Ebbut AF; Elsdon-Dew RW; Murphy JE
    J Int Med Res; 1978; 6(6):494-8. PubMed ID: 720740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ; Harron DW; Kinney C; Shanks RG
    Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
    Ebbutt AF; Elsdon-Dew RW
    J Int Med Res; 1979; 7(6):524-7. PubMed ID: 520655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
    Forrest WA
    J Int Med Res; 1981; 9(6):490-4. PubMed ID: 7033014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
    Goble AJ
    Med J Aust; 1975 Jan; 1(SP2):14-7. PubMed ID: 1124020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

  • 17. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double-blind cross-over study with cyclopenthiazide.
    Krogsgaard AR; Trap-Jensen J; Hartling O; Svendsen TL
    Acta Med Scand Suppl; 1976; 602():110-3. PubMed ID: 800315
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
    Davies R; Payne NN; Slater JD
    Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.